Novavax Inc. (NVAX)
NASDAQ: NVAX
· Real-Time Price · USD
9.58
0.15 (1.59%)
At close: Aug 15, 2025, 3:59 PM
9.54
-0.41%
After-hours: Aug 15, 2025, 04:11 PM EDT
1.59% (1D)
Bid | 9.54 |
Market Cap | 1.56B |
Revenue (ttm) | 1.08B |
Net Income (ttm) | 422.82M |
EPS (ttm) | 2.22 |
PE Ratio (ttm) | 4.32 |
Forward PE | -418.25 |
Analyst | Hold |
Ask | 9.56 |
Volume | 6,621,196 |
Avg. Volume (20D) | 7,869,062 |
Open | 9.49 |
Previous Close | 9.43 |
Day's Range | 9.27 - 9.89 |
52-Week Range | 5.01 - 15.22 |
Beta | 2.50 |
About NVAX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol NVAX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for NVAX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsEarnings Surprise
Novavax has released their quartely earnings
on Aug 6, 2025:
Next Earnings Release
Novavax Inc. is scheduled to release its earnings on
Nov 11, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 week ago
+12.63%
Novavax shares are trading higher after the compan...
Unlock content with
Pro Subscription
2 months ago
-0.78%
Shares of vaccine stocks are trading higher following a report indicating FDA advisers will consider if COVID-19 vaccines should target the LP.8.1 subvariant for 2025-2026.

1 week ago · fool.com
Novavax (NVAX) Profit Jumps on MilestoneNovavax (NVAX) Profit Jumps on Milestone